Charles River Laboratories | CRL - 净收入



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 14.96B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


净收入 更改 日
Agilent USD 339M 34M 2026-03
Align Technology USD 108.29M 4.48M 2026-06
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Cardinal Health USD 398M 1000K 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Cigna USD 1.66B 6M 2026-06
Concord Medical Services Hldg CNY -65.68M 38.54M 2025-12
CVS Health USD 2.98B 36M 2026-06
Danaher USD 870M 159M 2026-06
Dentsply International USD 37M 47M 2026-06
Elevance Health USD 1.46B 301M 2026-06
Humana USD 694M 492M 2026-06
Illumina USD 207M 73M 2026-06
Incyte USD 585.6M 282.27M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Laboratory Of America USD 298.7M 20.9M 2026-06
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
McKesson USD 614M 1.07B 2026-06
Merck EUR 490M 169M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Quest Diagnostics USD 320M 69M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Thermo Fisher Scientific USD 1.74B 85M 2026-06
United Therapeutics USD 333M 58.1M 2026-06
UnitedHealth USD 5.48B 796M 2026-06
Veradigm USD -59.82M 74.35M 2022-12
Waters USD -136M 64M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06